RxDoctor Payments Data

Johnny Chung, MD

Plastic and Reconstructive Surgery · Allentown, PANPI 1932188620

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,500 of the $18,918 with a category attached, or 81.9%. AbbVie accounts for 84.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $11,248 and has fallen 86.4% since, to $1,526 in 2025. Among plastic and reconstructive surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,918in general payments, 2019–2025

Across 119 payments — averaging $158.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$16K
  • Novus Surgical Consultants$696
  • Merz North America, Inc.$474
  • Arthrex$448
  • Mentor Worldwide LLC$421
  • Revance Therapeutics, Inc.$252
  • plus $618 from 16 others

What the payments were for

  • Speaking & faculty fees$15,50082%
  • Travel & lodging$9245%
  • Food & beverage$2,49413%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,918 in reported general payments places this provider in the 90th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.

See all plastic and reconstructive surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$5,192
Medicare patients
11
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin25$160
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$144
ValacyclovirValacyclovir Hcl17$68
Lorazepam12$6

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →